Takeda completes sale of its japan consumer health care business unit to blackstone

Osaka, japan--(business wire)--takeda pharmaceutical company limited (tokyo:4502) (nyse:tak) (“takeda”) today announced the completion of its previously-announced sale of takeda consumer healthcare company limited (“tchc”) to oscar a-co kk, a company controlled by funds managed by the blackstone group inc. and its affiliates (collectively “blackstone”) for a total value of jpy 242.0 billion1. this divestment agreement was first announced in august 2020. following the transfer of shares, tchc wi
TAK Ratings Summary
TAK Quant Ranking